The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

The closed system transfer devices (CSTDs) market has been expanding swiftly in recent years. It is expected to grow from $0.91 billion in 2023 to $1.04 billion in 2024, with a compound annual growth rate (CAGR) of 14.2%.

• Key Growth Factors:
  • Increased approvals of oncology drugs.
  • Rising focus on occupational safety in healthcare settings.
  • Growing need to curb needlestick injuries and exposure to hazardous drugs.
  • Increased awareness about the dangers of cytotoxic drug exposure.
  • Expansion in the chemotherapy patient population.

Future Market Projections: Sustained Expansion

The CSTDs market is expected to maintain its rapid growth trajectory, reaching $1.78 billion by 2028, with a CAGR of 14.3%.

• Drivers of Future Growth:
  • Rising cancer incidence globally.
  • Increased need for monitoring compliance in drug management.
  • Growing awareness and implementation of CSTDs for hazardous drug transportation.
  • Escalation in drug approvals, particularly for cancer treatments.

Read More On The Closed System Transfer Devices  Market Report 2024 https://www.thebusinessresearchcompany.com/report/closed-system-transfer-devices-global-market-report

Rising Cancer Incidence: A Significant Market Driver

The increasing incidence of cancer is a crucial factor driving the growth of the CSTDs market.

• Impact of Cancer:
  • Cancer cases are increasing due to factors such as lifestyle changes, environmental exposures, and infections.
  • CSTDs are vital in cancer treatment, protecting healthcare workers and patients from the risks associated with chemotherapy drugs.
  • Their use ensures a safer healthcare environment and improves treatment outcomes for cancer patients.
• Statistics Highlight:
  • The global cancer burden is expected to reach 28.4 million cases by 2040, a 47% increase from 2020.
  • In the United States alone, 1,958,310 new cancer cases and 609,820 cancer-related deaths were projected for 2023.

Innovations in CSTDs: Enhancing Safety and Efficacy

Innovation is key in advancing the safety and efficacy of CSTDs in drug handling.

• Next-Generation Devices:
  • Companies are developing advanced CSTDs to meet the evolving needs of healthcare settings.
  • For instance, B. Braun Medical Inc. launched the OnGuard 2 CSTD, which integrates enhanced features for easy operation and compliance with quality standards for handling hazardous drugs.
• Product Example:
  • The OnGuard 2 CSTD was specifically tested with actual hazardous drugs for vapor containment, positioning it as a leader in CSTD air-cleaning technology.

Strategic Partnerships: Expanding Market Reach

Strategic agreements and partnerships are further propelling the CSTDs market.

• Notable Agreement:
  • In April 2021, Fresenius Kabi entered into an exclusive U.S. distribution agreement with Corvida Medical for the HALO CSTD.
  • The HALO system is designed to prevent environmental contamination and exposure to drug vapors during the handling of hazardous drugs like chemotherapy.

Market Segmentation and Regional Insights

The CSTDs market is segmented by type, technology, closing mechanism, and end user.

• Market Segments:
  • Type: Needleless Systems, Membrane-to-Membrane Systems.
  • Technology: Diaphragm-Based, Compartmentalized, Filtration.
  • Closing Mechanism: Color-to-Color Alignment Systems, Push-to-Turn Systems, Click-to-Lock Systems, Luer-Lock Systems.
  • End User: Hospitals and Clinics, Oncology Centers, Other End Users.
• Regional Insights:
  • North America was the largest region in the CSTDs market in 2023.
  • Asia-Pacific is expected to be the fastest-growing region during the forecast period, highlighting its increasing significance in global healthcare.

Request for A Sample Of The Global Closed System Transfer Devices Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=15767&type=smp